SCIENTIFIC BACKGROUND

CDKL5, FOXG1, MECP2

Scientific background

Rett syndrome is an X-linked dominant neurodegenerative disorder (frequency 1:10,000) that occurs predominantly in females. In the classic course, children lose previously acquired abilities including meaningful hand movements, speech, and social interaction at between 6 and 18 months of age after initially inconspicuous development. A main symptom is the development of stereotypical hand movements. Other symptoms include delayed growth, microcephaly, gait ataxia, episodes of apnea or hyperpnea, sleep disturbances, progressive scoliosis, and seizures. The few affected males predominantly present with severe neonatal encephalopathy.

 

The disorder is caused by pathogenic variants in the MECP2 gene that encodes a protein involved in the regulation of gene expression by methylation. The severity of the disorder is influenced by the pattern of X inactivation and the type of variant. Most pathogenic variants arise de novo resulting in a low risk of recurrence. In rare cases, the pathogenic variant is already present in combination with a non-random X-inactivation in the clinically inconspicuous mother, so that a diagnosis can be made in the mother of an affected child. Since germ cell mosaics have been observed in isolated cases, prenatal diagnosis may also be appropriate in the absence of maternal variant detection. Pathogenic variants in the CDKL5 gene have been found in a few patients with a non-classical form of Rett syndrome with early-onset seizures (Rett syndrome, atypical).

 

Atypical Rett syndrome was first described in 1985 in a girl with benign neonatal seizures (BNS) and later a disease with a very similar clinical course to classical Rett syndrome. To date, patients have been mainly characterized by an early-onset therapy-resistant epilepsy and, in later stages, by severe psychomotor developmental delay. In addition to BNS, other seizure types may occur. The EEG is not typical but depends on age and the seizure type. Unlike Rett syndrome, there is no initial phase of seemingly normal development.

 

The diagnostic criteria according to Artuso et al. (2010) are:

  • inconspicuous prenatal development
  • irritability, vigilance disturbances, and sucking difficulties in the postnatal period before the onset of the first epileptic seizures
  • early childhood epilepsy with onset between the first week and the fifth month of life
  • stereotypical hand movements
  • severe psychomotor developmental delay
  • severe hypotonia

 

Since 2005, it has been known that variants in the CDKL5 gene (Xp22) are causative for this X-linked dominant atypical Rett syndrome. The CDKL5 gene encodes the cyclin dependent kinase-like 5 protein, which, together with the methyl CpG binding protein 2 (MECP2), plays an important role in the regulation of gene expression by methylation. Pathogenic variants in the CDKL5 gene lead to misregulation of gene expression in several genes. Furthermore, pathogenic variants in the FOXG1 gene have also been identified in female and male patients with a congenital variant of Rett syndrome and also in patients with symptoms of classical Rett syndrome (without a pathogenic MECP2 variant). The clinical presentation in patients with pathogenic FOXG1 variants is variable and associated with severe developmental delay among other symptoms. Genotype-phenotype studies have shown that severe microcephaly (-4 to -6 standard deviations) is always present in this group of patients.

 

The FOXG1 gene product is a transcriptional repressor expressed in neural precursor cells of developing neuroepithelium. Based on data collected to date, it can be predicted that FOXG1 haploinsufficiency leads to microcephaly and a thin cortex with abnormal cortical architecture resulting in cognitive and developmental deficits.

 

References

Gold et al. 2018, ACS Chem Neurosci 9:167 / Leonard et al. 2017, Nat Rev Neurol 13: 37 / Temudo et al. 2011, Brain Dev 33:69 / Psoni et al. 2010, Pediatr Res 67:551 / Saunders et al. 2009, Am J Med Genet A 149A:1019 / Hite et al. 2009, Biochem Cell Biol 87:219 / Ghosh et al. 2008, J Biol Chem 283:20523 / Williamson et Christodoulou 2006, Eur J Hum Genet 14:896 / Bienvenu et Chelly 2006, Nat Rev Genet 7:415, Erratum in: 7:583 (2006) / Weaving et al. 2006, Clin Genet 69:1 / Wan et al. 1999, Am J Hum Genet 65:1520 / Rett 1966, Wien Med Wschr, 116:723

GENES

CDKL5, FOXG1, MECP2
How to order

LATEST ARTICLES

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more